YDYugang Diao

Yugang Diao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yugang Diao has a total of 98 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Remimazolam versus propofol for elderly patients undergoing laparoscopic gastrointestinal surgery: a randomized trial concentrating on delirium and hemodynamic stability

    by Hongna Fan, Xiaotong Chen, Linlin Xu, Bin Zou, Da Li, Cheng Zhang, Jianyu Zu, Yugang Diao

    Background: Postoperative delirium (POD) is a common complication in elderly surgical patients that can impede recovery. While remimazolam offers superior hemodynamic stability compared to propofol, its impact on POD incidence remains unclear. This randomized trial aimed to determine whether two induction doses of remimazolam are more effective than propofol in reducing POD and improving hemodynamic stability in older patients undergoing laparoscopic gastrointestinal surgery. Methods: In this prospective trial, 186 patients (aged 60–80 years) were randomized to receive anesthesia induction with remimazolam 0.15 mg/kg (R1), remimazolam 0.3 mg/kg (R2), or propofol 1.5 mg/kg (P). The primary endpoint was the incidence of POD within 5 days post-surgery, assessed using the 3-Minute Diagnostic Interview for Confusion Assessment Method. Secondary endpoints included hemodynamic parameters, recovery times, and adverse events. Results: The incidence of POD was 12.9% in the R1 group, 11.3% in the R2 group, and 6.5% in the P group ( P = 0.467). Both remimazolam groups exhibited significantly higher mean arterial pressure following induction and intubation (both P < 0.05). Furthermore, remimazolam was associated with a lower incidence of treated hypotension ( P = 0.010), fewer bradycardia events ( P < 0.001), and reduced vasopressor requirements ( P < 0.05). However, the time to loss of consciousness ( P < 0.001) and extubation time ( P < 0.001) were longer with remimazolam. Conclusions: Remimazolam at induction doses of 0.15 mg/kg and 0.3 mg/kg did not reduce the incidence of POD compared with propofol. Nevertheless, the study was not adequately powered to exclude a clinically relevant difference in POD incidence given the substantially lower-than-expected event rate, as no statistically significant between-group difference was detected. In addition, remimazolam at these doses was associated with higher post-induction blood pressure, fewer hypotensive events, and lower vasopressor requirements compared with propofol. Therefore, remimazolam at these induction doses may serve as suitable alternatives for this vulnerable patient population. Clinical trial registration: https://www.chictr.org.cn , Chinese Clinical Trial Registry ChiCTR2400082176.

  • Open Access

    Median effective dose and 95% effective dose of oliceridine combined with ciprofol for painless gastroscopy: a dose-finding study based on Dixon’s up-and-down method

    by Xikun Sun, Pei Song, Bin Zou, Yimeng Zhuang, Xiaohang Han, Jianyu Zu, Yugang Diao

    Objective: To determine the median effective dose and estimate 95% effective dose of oliceridine combined with ciprofol for suppressing gastroscope insertion responses, stratified by sex. Methods: This prospective, sex-stratified trial enrolled patients between 16 January and 31 March 2026, at the General Hospital of Northern Theater Command. Patients, stratified into separate male and female cohorts, received an individualized dose of oliceridine followed by a fixed dose of ciprofol (0.4 mg/kg) for anesthesia induction. The oliceridine dose was determined using a modified Dixon up-and-down method, with an initial dose of 0.02 mg/kg. Subsequent doses increased or decreased by a ratio of 1.0:1.1 based on positive or negative responses. The positive response was defined as retching, coughing, body movement, or a greater than 30% increase in mean arterial pressure or heart rate within 1 min of insertion. The trial terminated upon reaching seven consecutive response reversals in each cohort. Results: A total of 29 male and 32 female patients completed the study. The ED 50 and ED 95 values of oliceridine were 12.74 μg/kg (95% CI: 9.48–14.76) and 17.69 μg/kg (95% CI: 15.32–40.14) in females, compared with 17.37 μg/kg (95% CI: 15.59–19.01) and 20.98 μg/kg (95% CI: 19.22–32.47) in males, respectively. In both the male and female cohorts, ciprofol consumption was significantly lower in the negative-response group than in the positive-response group, whereas oliceridine requirements were higher. At gastroscope insertion, both MAP and HR decreased, with the negative-response group showing significantly lower values. SpO 2 levels at insertion were significantly higher than baseline values. There were no significant differences in the incidence of adverse events between the two sexes. Conclusion: For day-case painless gastroscopy, the ED 50 of oliceridine combined with ciprofol (0.4 mg/kg) was 12.74 μg/kg in females and 17.37 μg/kg in males, with ED 95 estimates of 17.69 μg/kg and 20.98 μg/kg, respectively.

  • Open Access

    Temporal Transcriptomic Changes in the Cingulate Cortex of Neuropathic Pain Mice

    by Guo-Quan Yao, Zhen-Ru Yuan, Xin-Tong Qiu, Cheng-Guo Jiang, Chong Zhang, Si-Zhe Feng, Guang-Xi Piao, Hong Ma, Zi-He Zhu, Yu-Gang Diao, et al.

    Background: Neuropathic pain (NP), a debilitating condition resulting from nervous system lesions, is poorly managed by current therapies. The cingulate cortex is crucial for affective pain processing, yet a comprehensive spatiotemporal understanding of its molecular changes in NP is lacking. Methods: We performed RNA sequencing to profile transcriptomic alterations in the anterior cingulate (ACC) and midcingulate (MCC) cortices of mice at two and four weeks after spared nerve injury. Bioinformatics analyses, including differential expression, functional enrichment, weighted gene co-expression network analysis, and protein–protein interaction (PPI) network construction, were employed. Results: We identified widespread, time-dependent transcriptional dysregulation in both regions, with differentially expressed genes increasing over time. Functional analyses confirmed central roles for synaptic plasticity and neuroinflammatory pathways, and further identified pathways related with neurodegeneration and mitochondrial dysregulationin NP pathogenesis. Subregion analysis revealed that the ACC exhibited broader pathway alterations than the MCC, including neuroinflammation (early phase) and mitochondrial dysfunction/neurodegeneration (late phase), indicating a progressive stress response unique to the ACC. PPI analysis identified stage-specific hub genes (e.g., early interferon-stimulated genes and late ribosomal proteins in ACC; persistent extracellular matrix components in MCC). Conclusions: This study provides a detailed transcriptomic atlas of the cingulate cortex in NP, reinforcing known synaptic and neuroinflammatory mechanisms, and suggests a possible role of mitochondrial dysregulation in NP pathogenesis. The findings provide a basis for further mechanistic studies.

  • Open Access

    Intestinal microbiota dynamics in postoperative delirium following cardiac surgery with cardiopulmonary bypass: an observational study

    by Shaoqiong Zhang, Xinyi Ma, Xiaodong Zhang, Bin Zou, Yingjie Sun, Yugang Diao

    Postoperative delirium (POD) is a common complication of cardiac surgery with cardiopulmonary bypass (CPB), and it is associated with systemic inflammation


  • Open Access

    Temporal Transcriptomic Changes in the Cingulate Cortex of Neuropathic Pain Mice

    by Guo-Quan Yao, Zhen-Ru Yuan, Xin-Tong Qiu, Cheng-Guo Jiang, Chong Zhang, Guang-Xi Piao, Hong Ma, Zi-He Zhu, Yu-Gang Diao, Felipe Fregni, et al.

    Background: Neuropathic pain (NP), a debilitating condition from nervous system le-sions, is poorly managed by current therapies. The cingulate cortex is crucial for affec-tive pain processing, yet a comprehensive spatiotemporal understanding of its molec-ular changes in NP is lacking. Methods: This study performed RNA sequencing to pro-file transcriptomic alterations in the anterior cingulate (ACC) and midcingulate (MCC) cortices of mice at two and four weeks after spared nerve injury. Bioinformatics anal-yses, including differential expression, functional enrichment, weighted gene co-expression network analysis, and protein-protein interaction (PPI) network con-struction, were employed. Results: We identified widespread, time-dependent tran-scriptional dysregulation in both regions, with differentially expressed genes increas-ing over time. Analyses confirmed central roles for synaptic plasticity and neuroin-flammatory pathways. Importantly, we uncovered significant dysregulation in prote-ostasis and mitochondrial function pathways, mechanisms shared with neurodegen-erative diseases. PPI analysis identified stage-specific hub genes (e.g., early interfer-on-stimulated genes and late ribosomal proteins in ACC; persistent extracellular ma-trix components in MCC). Conclusions: This study provides a detailed transcriptomic atlas of the cingulate cortex in NP, reinforcing known mechanisms while elucidating novel dysregulation in protein homeostasis and mitochondrial pathways. The findings highlight convergent pathophysiology with neurodegeneration and offer a new theo-retical framework with potential therapeutic targets for chronic NP.

  • Open Access

    Analgesic Efficacy and Adverse Effects of Epidural Ropivacaine Combined with Equipotent Alfentanil or Sufentanil for Labor Analgesia: A Multicenter Randomized Controlled Single-Blind Trial

    by Xiao Jiang, Yufang Xiu, Chang Jia, Bo Han, Jianyu Zu, Shanni Zhang, Nana Han, Lingling Pan, Huixuan Sun, Jing Li, et al.

    Introduction Epidural analgesia has shown high maternal–fetal safety and satisfactory analgesia. Sufentanil is associated with a high risk of pruritus, nausea, and vomiting for epidural labor analgesia. Alfentanil is characterized by a rapid onset and is also used for labor analgesia. The study aimed to compare the analgesic efficacy and adverse effects of epidural ropivacaine combined with equipotent doses of alfentanil or sufentanil for labor analgesia, and to provide evidence for optimizing obstetric analgesic regimens. Methods In this multicenter, randomized, controlled, single-blind trial conducted at four tertiary hospitals in China between June 2023 and June 2024, 442 nulliparous women with singleton, term pregnancies were enrolled. Participants were randomly assigned (1:1) to receive epidural 0.075% ropivacaine combined with either 4 μg/ml alfentanil (group A) or 0.2 μg/ml sufentanil (group S). Analgesia was delivered via a programmed intermittent epidural bolus (PIEB) plus patient-controlled epidural analgesia (PCEA) regimen (10 ml bolus, 50-min interval, 3 ml/h background infusion, 8-ml patient-controlled bolus, 20-min lockout). The onset of analgesia, defined as the median time from drug administration to the first recording of a visual analogue scale (VAS) score ≤ 3 within 30 min was the primary outcome. Hemodynamic parameters, labor characteristics, analgesic consumption, maternal satisfaction, neonatal outcomes, and adverse events were recorded as secondary outcomes. Results The median onset time of analgesia was significantly shorter in the alfentanil group compared with the sufentanil group (8.0 min vs. 10.0 min, P < 0.001). No significant differences were observed between groups in blood pressure, heart rate, SpO₂, fetal heart rate, Bromage scores, VAS scores at subsequent time points, uterine pressure, sensory block level, body temperature, duration of analgesia, labor duration, mode of delivery, oxytocin use, total drug consumption, maternal satisfaction, or neonatal Apgar scores (all P > 0.05). Adverse events such as pruritus, nausea, vomiting, urinary retention, and lower limb numbness were infrequent and comparable between groups. Conclusions Both alfentanil and sufentanil, when combined with 0.075% ropivacaine, provide effective and safe epidural labor analgesia. However, alfentanil offers the advantage of a faster onset of analgesia, making it a valuable alternative to sufentanil in clinical practice. Trial Registration Chinese Clinical Trial Registry, ChiCTR2300072104, Date of registration: June 2, 2023.


  • Open Access

    Esketamine as an opioid-sparing adjuvant for epidural labour analgesia: a randomised, double-blind trial evaluating postpartum depression

    by Yi-Ying Zhang, Xu-Li Cheng, Li Liu, Lin Li, Yugang Diao

    Opioid-based epidural analgesia, while effective, is frequently associated with maternal side effects such as pruritus and potential central sensitisation.


  • Open Access

    Knowledge mapping and emerging trends in cognitive impairment associated with chronic pain: A 2000–2024 bibliometric study

    by Li-Yuan Zhao, Guang-Fen Zhang, Jian-Jun Yang, Yu-Gang Diao, Kenji Hashimoto


  • Open Access

    STING Driving Synaptic Phagocytosis of Hippocampal Microglia/Macrophages Contributes to Cognitive Impairment in Sepsis‐Associated Encephalopathy in Mice

    by Xin Lv, Min Jia, Xiao Feng, Jia‐Xiong Jian, Jian‐Jun Yang, Da‐Qing Ma, Mu‐Huo Ji, Yu‐Gang Diao, Jin‐Chun Shen

    Background: Sepsis‐associated encephalopathy (SAE) is a serious neurologic complication in septic patients with poor prognoses. There is increasing evidence that stimulator of interferon genes (STING) plays a crucial role in neuroinflammation and cognitive impairment. However, whether sepsis associated with STING changes contributes to cognitive impairment is unknown.Methods: Male adult mice received lipopolysaccharide (LPS) injection (a single dose of 4 mg/kg; i.p. injection) and 30 min later, they were injected with STING inhibitor C‐176 (a single dose of 30 mg/kg, i.p. injection). Behavioral assessments, biochemical measurements, in vivo and ex vivo electrophysiology techniques were conducted to investigate the association between LPS‐induced STING overexpression and cognitive function.Results: Cognitive impairment was associated with STING overexpression and activation of microglia/macrophages. Phagocytosis of microglia/macrophages as well as complement C1q release were increased after LPS injection, leading to abnormal pruning synapses, synaptic transmission reduction, long‐term potentiation (LTP) impairment, as well as abnormal theta oscillation in the hippocampus. Notably, STING inhibitor C‐176 significantly reversed these changes.Conclusions: Sepsis‐induced STING overexpression in microglia/macrophages may lead to synaptic loss, abnormal theta oscillation and LTP impairment through microglia/macrophages activation and complement C1q modulation, ultimately resulting in cognitive impairment.